DovaVision UC

Sharper Insights. Smarter Decisions.

DovaVision uses advanced AI to automate scoring and rapidly analyze Ulcerative Colitis (UC) disease severity from endoscopy videos.

Designed for both research and clinical trials, it ensures enriched, consistent, objective, and efficient evaluation of UC

Schedule a Demo

Quantify subtle variations in inflammation, ulceration, and other disease markers across different regions of the colon.

Standardize outputs with AI-driven analysis to improve reproducibility and enable scalable decision-making.

Analyze disease features that underpin scoring, enhancing precision and transparency of disease grading.

Generate dynamic severity analysis across the full procedure —available as raw data for further analysis and intuitive visual outputs.

FOR CLINICAL TRIALS

Reliable AI for Smarter Clinical Trials

Detect nuanced changes in disease activity

Proactively ensure data quality and consistency

Scale without increasing manual workload

Standardized, deterministic scoring you can trust

Banner image of 2 scientists looking at a computer

WE ARE

Visual data that moves discovery forward

DovaVision unlocks deeper biological and therapeutic insights from endoscopic video, using explainable AI to surface subtle changes and hidden disease signals.

Detect subtle shifts. Uncover hidden patterns.

DovaVision’s explainable AI identifies nuanced biological and procedural signals from endoscopic data, providing new layers of insight into drug response, disease progression, and therapeutic impact.

Quantify treatment effects with objective AI endpoints.

Support biomarker discovery with visual and functional data generated from video-based scoring. DovaVision can support surrogate endpoints and enhance exploratory analyses.

Quantify response trajectories over time.

DovaVision enables consistent scoring across visits allowing researchers to monitor disease progression or therapeutic response with objective, reproducible endpoints over time. Ideal for longitudinal analysis, outcomes-based validation, and identifying early signals of efficacy.

Integrate visual data with multi-omic profiles

Pair DovaVision’s imaging biomarkers with other data sets such as genomic, transcriptomic, and clinical data to explore disease pathways, discover new biomarkers, and personalize treatments.